Indira Turney, an associate research scientist in the Department of Neurology, is studying how lived experiences affect they way the brain ages in diverse populations.
Even in people with complete paralysis after spinal cord injury, some nerves fibers are preserved. A Columbia physician-scientist is developing a new way to salvage those fibers and restore movement.
A newly discovered Alzheimer’s gene appears to drive the first appearance of amyloid plaque in the brain and could lead to new therapies that prevent the disease from developing.
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
A new study shows how modifications to the tau protein may influence the different ways it can misfold in the brain, which is closely linked to the type of neurodegenerative disease that develops.
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.